Jon Congleton is Chief Executive Officer of Mineralys Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Mineralys Therapeutics, Inc.
15 Feb 24
4
Mineralys Therapeutics, Inc.
27 Nov 23
4
Mineralys Therapeutics, Inc.
8 Sep 23
4
Mineralys Therapeutics, Inc.
21 Aug 23
4
Mineralys Therapeutics, Inc.
11 Aug 23
4
Mineralys Therapeutics, Inc.
21 Mar 23
4
Mineralys Therapeutics, Inc.
13 Feb 23
3
Mineralys Therapeutics, Inc.
9 Feb 23
4
Nivalis Therapeutics, Inc.
14 Sep 16
4
Nivalis Therapeutics, Inc.
17 Jun 16
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Nov 23 | MLYS Mineralys Therapeutics | Common Stock | Buy | Acquire P | No | No | 5.9661 | 4,250 | 25.36 k | 1,049,068 |
6 Sep 23 | MLYS Mineralys Therapeutics | Common Stock | Buy | Acquire P | No | No | 12.08 | 2,250 | 27.18 k | 1,044,818 |
17 Aug 23 | MLYS Mineralys Therapeutics | Common Stock | Buy | Acquire P | No | No | 12.1 | 2,250 | 27.23 k | 1,042,568 |
11 Aug 23 | MLYS Mineralys Therapeutics | Common Stock | Buy | Acquire P | No | No | 12.89 | 2,000 | 25.78 k | 1,040,318 |
17 Mar 23 | MLYS Mineralys Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 15.44 | 99,800 | 1.54 mm | 99,800 |